Cargando…

Profiling of plasma metabolomics in patients with hepatitis C-related liver cirrhosis and hepatocellular carcinoma

AIM OF THE STUDY: The diagnosis of hepatocellular carcinoma (HCC) is usually late, due to the lack of early detection of biomarkers for HCC. Metabolomics analysis has emerged as a useful tool for studying human diseases. The objective of the study was to investigate the differences in plasma metabol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nomair, Azhar Mohamed, Madkour, Marwa Ahmed, Shamseya, Mohammed Mohammed, Elsheredy, Heba Gaber, Shokr, Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935851/ https://www.ncbi.nlm.nih.gov/pubmed/31893244 http://dx.doi.org/10.5114/ceh.2019.89478

Ejemplares similares

The clinical significance of serum miRNA-224 expression in hepatocellular carcinoma
por: Nomair, Azhar Mohamed, et al.
Publicado: (2020)

Seattle protocol vs narrow band imaging guided biopsy in screening of Barrett's esophagus in gastroesophageal reflux disease patients
por: Elsheaita, Ahmed, et al.
Publicado: (2020)

MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes
por: Elemeery, Moustafa Nouh, et al.
Publicado: (2019)

TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis
por: Nomair, Azhar Mohamed, et al.
Publicado: (2021)

Study of Dickkopf-1 (DKK-1) in patients with chronic viral hepatitis C-related liver cirrhosis with and without hepatocellular carcinoma
por: Eldeeb, Mona Kamal, et al.
Publicado: (2020)

Autophagy, apoptosis, vitamin D, and vitamin D receptor in hepatocellular carcinoma associated with hepatitis C virus
por: Abdel-Mohsen, Mohamed Ahmed, et al.
Publicado: (2018)

β-arrestin-2 predicts the clinical response to β-blockers in cirrhotic portal hypertension patients: A prospective study
por: Lashen, Sameh A, et al.
Publicado: (2022)

Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
por: He, Michelle Junyi, et al.
Publicado: (2022)

Peripheral Mononuclear Cells Surface Markers Evaluation in Different Stages of Hepatocellular Carcinoma; in a Trial for Early and Accurate Diagnosis in Patients with Post-Hepatitis Liver Cirrhosis and Unremarkable Raised AFP
por: Osman, Heba Ahmed, et al.
Publicado: (2023)

Diagnostic performance of RASSF1A and CDKN2A gene methylation versus α-fetoprotein in hepatocellular carcinoma
por: Nomeir, Hanan, et al.
Publicado: (2022)

Hepatocellular carcinoma in the absence of liver cirrhosis in a treated hepatitis C virus patient
por: Al Nozha, Omar M., et al.
Publicado: (2009)

The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma
por: Shen, Jiliang, et al.
Publicado: (2017)

The role of serum visfatin and vaspin in hepatocellular carcinoma in hepatitis C-related liver cirrhosis
por: Abdelhamed, Walaa, et al.
Publicado: (2023)

Circulating liver cancer stem cells and their stemness-associated MicroRNAs as diagnostic and prognostic biomarkers for viral hepatitis-induced liver cirrhosis and hepatocellular carcinoma
por: Hassan, Marwa, et al.
Publicado: (2022)

Predicting the risk of portal vein thrombosis in patients with liver cirrhosis and hepatocellular carcinoma
por: Serag, Waleed Mohamed, et al.
Publicado: (2020)

Genetic profile of MIF single nucleotide polymorphism (rs755622 G>C) in hepatocellular carcinoma among Egyptian patients
por: Osman, Heba Ahmed, et al.
Publicado: (2023)

Urinary Biomarkers of Acute Kidney Injury in Patients with Liver Cirrhosis
por: Qasem, Anass Ahmed, et al.
Publicado: (2014)

Urinary Biomarkers of Acute Kidney Injury in Patients With Liver Cirrhosis
por: Ahmed, Qasem Anass, et al.
Publicado: (2014)

Hepatitis B Related Liver Cirrhosis in Oman
por: Al-Naamani, Khalid, et al.
Publicado: (2022)

Platelet transfusion in patients with liver cirrhosis cross-talk with neutrophil: Prospective study
por: Hassouna, Mona Mahmoud, et al.
Publicado: (2023)

Impact of sustained virologic response in regression of portal hypertension in Egyptian patients with hepatitis C virus-associated cirrhosis and portal hypertension
por: Faheem, Heba Ahmed, et al.
Publicado: (2022)

Metabolomic Signatures of Autoimmune Hepatitis in the Development of Cirrhosis
por: Li, Shan-shan, et al.
Publicado: (2021)

Profiling of the circadian metabolome in thioacetamide‐induced liver cirrhosis in mice
por: Fujisawa, Koichi, et al.
Publicado: (2017)

LC/MS-Based Global Metabolomic Identification of Serum Biomarkers Differentiating Hepatocellular Carcinoma from Chronic Hepatitis B and Liver Cirrhosis
por: Pan, Hong Y., et al.
Publicado: (2021)

Serum copeptin is associated with major complications of liver cirrhosis and spontaneous bacterial peritonitis
por: Abudeif, Ahmed, et al.
Publicado: (2023)

Biomarker Discovery for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Using Untargeted Metabolomics and Lipidomics Studies
por: Rashid, Md Mamunur, et al.
Publicado: (2023)

Value of Bile Acids in Diagnosing Hepatitis C Virus-Induced Liver Cirrhosis and Hepatocellular Carcinoma
por: Khalil, Ashraf, et al.
Publicado: (2022)

Programmed death-ligand 1 (PD-L1) polymorphisms as predictive biomarkers for the development of liver cirrhosis and hepatocellular carcinoma in HCV Egyptian patients
por: Hassan, Marwa, et al.
Publicado: (2022)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

Emerging roles of bile acids in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma
por: Xun, Zhen, et al.
Publicado: (2023)

Plasma levels of methylated septin 9 are capable of detecting hepatocellular carcinoma and hepatic cirrhosis
por: He, Na, et al.
Publicado: (2020)

Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis
por: Pose, Elisa, et al.
Publicado: (2021)

Hepatic adenomatosis in liver cirrhosis
por: Gordic, Sonja, et al.
Publicado: (2017)

Pathway-Based Integrative Analysis of Metabolome and Microbiome Data from Hepatocellular Carcinoma and Liver Cirrhosis Patients
por: Kim, Boram, et al.
Publicado: (2020)

Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening
por: Simão, Adélia, et al.
Publicado: (2015)

The Expression of Embryonic Liver Development Genes in Hepatitis C Induced Cirrhosis and Hepatocellular Carcinoma
por: Behnke, Martha, et al.
Publicado: (2012)

Unusual Ileocecal Ulcers after Liver Transplantation for Hepatitis B Cirrhosis and Hepatocellular Carcinoma
por: He, Kang, et al.
Publicado: (2022)

De Novo Hepatocellular Carcinoma in Hepatitis C-Related Cirrhosis: Are Advanced Glycation End Products a Key Driver?
por: Abdel-Razik, Ahmed, et al.
Publicado: (2021)

Low Serum 25-Hydroxy Vitamin D (25-OHD) and Hepatic Encephalopathy in HCV-Related Liver Cirrhosis
por: Afifi, Mohamed Abd Ellatif, et al.
Publicado: (2021)

Gastric antral vascular ectasia in hepatitis C virus related liver cirrhosis: Fetching for predictors
por: Fouad, Magdy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5ksj2mri6im26i4bks4buk8ume